Adjunctive bright light therapy for non-seasonal major depressive disorder: a randomized controlled trial.
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
This double-blind, randomized controlled trial assessed bright light therapy (BLT) augmentation efficacy compared with placebo light in treating non-seasonal major depressive disorder. The study participants belonged to a subtropical area (24.5°–25.5°N) with extensive daylight and included outpatients who had received stable dosages and various regimens of antidepressive agents for 4 weeks before enrollment. The outcomes were the 17-item Hamilton Depression Rating Scale, Montgomery–Asberg Depression Rating Scale, and Patient Health Questionnaire-9, which were assessed at weeks 1, 2, and 4. A total of 43 participants (mean age 45 years, ranging from 22–81) were randomized into the BLT [n = 22] and placebo light groups [n = 21]. After a 4-week administration of morning light therapy (30 min/day), depressive symptoms did not reduce significantly, which might be due to the small sample size. Nonetheless, this study had some strengths because it was conducted in warmer climates, unlike other studies, and examined diverse Asians with depression. Our findings suggest that several factors, such as poor drug response, different antidepressive regimens, duration of BLT, and daylength variability (i.e., natural daylight in the environment) may influence the utility of add-on BLT. Researchers may consider these important factors for future non-seasonal depression studies in subtropical environments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“there are crescent data of studies enrolled in a subtropical environment, which experiences unequal daylight duration throughout the year in comparison to those in a temperate zone.6,15,16,20”
From Bright Light Therapy for Nonseasonal Depressive Disorders (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Seven new relevant studies6,12,13,14,15,16,18 comprising nearly 3 times the sample size of the most similar previous meta-analyses have been added to the literature, possibly adding important insights to the body of evidence.”
From Bright Light Therapy for Nonseasonal Depressive Disorders (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Niederhofer, H. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.11m01194 · Cited by 31
RetractedThe PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“HAMD-17 is a 17-item scale that assesses the overall levels of severity of depressive symptoms and responses to treatment [15].”
BackgroundA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 1×
“MADRS was developed to assess changes in the severity of depression [24].”
MethodRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Specifically, only one-third of patients achieve remission from depression after first-line antidepressant therapy, one-half achieve remission after two lines of antidepressant treatments, and approximately two-thirds of all patients achieve remission after four lines of antidepressant therapy [1].”
BackgroundA self-assessment questionnaire to determine morningness- eveningness in human circadian rhythms
Home, J. K. (1976) · Medical Entomology and Zoology · Cited by 4,783
(1976) · PubMed · Cited by 3,979
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“The secondary outcomes included the change of the HAMD-17 total score from baseline to different visits, the rate of response (proportion of patients with ≥50% reductions of the HAMD-17 score) [27], and the rate of remission (defined as HAMD-17 score ≤ 7) [28].”
BackgroundSeverity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199 · cited 1×
“The severity ranges for MDD on HAMD-17 are mild (8–16), moderate (17–23), and severe (≥24) [16].”
BackgroundKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148 · cited 1×
“However, the factor structure of HAMD is multidimensional and only partly related to the main conception of MDD in DSM-IV [49].”
BackgroundFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927 · cited 1×
“Maier–Philipp severity subscale [19], Gibbons global depression severity scale [20], Santen scale [21], anxiety subscale [22], and retardation subscale [23] (Table S1).”
BackgroundGolden, R. N., Gaynes, B. N., Ekstrom, R. D., Hamer, R. M., Jacobsen, F. M., Suppes, T., Wisner, K. L., & Nemeroff, C. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.656 · Cited by 896 · cited 1×
“BLT has been recommended by the American Psychiatric Association for the treatment of seasonal affective disorder (SAD) because of its established efficacy [4].”
Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects
Terman, M., & Terman, J. S. (2005) · CNS Spectrums · doi:10.1017/s1092852900019611 · Cited by 546 · cited 1×
“The side effects of light therapy were measured using the adverse events scale [32,33] at each visit.”
MethodBech, P., Gram, L. F., Dein, E., Jacobsen, O., Vitger, J., & Bolwig, T. G. (1975) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1975.tb00002.x · Cited by 489 · cited 1×
“The scores of the full HAMD scale were divided into the following six subscales: Bech melancholia scale [18],”
MethodValidity and Reliability of the Chinese Hamilton Depression Rating Scale
Zheng, Y., Zhao, J., Phillips, M., Liu, J., Cai, M., Sun, S., & Huang, M. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.5.660 · Cited by 423 · cited 1×
“Good inter-rater reliability and internal reliability have been found in the Chinese version of HAMD-17 [17].”
BackgroundRavindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337
Lam, R. W., Levitt, A. J., Levitan, R. D., Michalak, E. E., Cheung, A. H., Morehouse, R., Ramasubbu, R., Yatham, L. N., & Tam, E. M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2235 · Cited by 275 · cited 1×
“Studies with positive findings had unique features such as the exclusion of patients with treatment-resistance depression [39], the use of a treatment period exceeding 4 weeks [39], approximately 75% of the patients with depression with melancholic features [40], about half of subjects with seasonal worsening without…”
BackgroundReflections On The 20th Anniversary Of Taiwan’s Single-Payer National Health Insurance System
Cheng, T.-M. (2015) · Health Affairs · doi:10.1377/hlthaff.2014.1332 · Cited by 238 · cited 1×
“Since accessing the psychiatrists was convenient in our study area [36], the long-term patient–psychiatrist relationship and assistants’ efforts were also contributing factors.”
BackgroundZimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.007 · Cited by 229 · cited 1×
“Moreover, the total scores and changes of MADRS and PHQ-9 scores, the rate of response (proportion of patients with ≥50% reductions of the MADRS score and PHQ-9 score), and the rate of remission (defined as MADRS score≤ 10) were recorded [29].”
BackgroundExactly what does the Hamilton depression rating scale measure?
Gibbons, R. D., Clark, D. C., & Kupfer, D. J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90037-3 · Cited by 223 · cited 1×
“Maier–Philipp severity subscale [19], Gibbons global depression severity scale [20], Santen scale [21], anxiety subscale [22], and retardation subscale [23] (Table S1).”
BackgroundPartial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options
Hirschfeld, R. M. A., Montgomery, S. A., Aguglia, E., Amore, M., Delgado, P. L., Gastpar, M., Hawley, C., Kasper, S., Linden, M., Massana, J., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0913 · Cited by 193 · cited 1×
“The secondary outcomes included the change of the HAMD-17 total score from baseline to different visits, the rate of response (proportion of patients with ≥50% reductions of the HAMD-17 score) [27], and the rate of remission (defined as HAMD-17 score ≤ 7) [28].”
BackgroundLiu, S.-I., Yeh, Z.-T., Huang, H.-C., Sun, F.-J., Tjung, J.-J., Hwang, L.-C., Shih, Y.-H., & Yeh, A. W.-C. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.04.013 · Cited by 192 · cited 4×
“Funding: This work was supported by the Ministry of Science and Technology, Taiwan (number: MOST-108-2314-B-195-001) and supported by MacKay Memorial Hospital, Taipei, Taiwan (number: MMH-108-147, MMH-109-98).”
BackgroundInfluentialSelf-citationBright light therapy for nonseasonal depression: meta-analysis of clinical trials
Al-Karawi, D., & Jubair, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.016 · Cited by 189 · cited 2×
“This observation is also supported by two meta-analyses that did not find robust evidence of efficacy for BLT as an adjunct to the antidepressant medication [6,34].”
MethodResultKeijzer, H., Smits, M. G., Duffy, J. F., & Curfs, L. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2013.12.001 · Cited by 171 · cited 1×
“Seventh, we did not examine biological correlates of the circadian rhythm such as salivary melatonin concentrations [54].”
BackgroundMorning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152 · cited 1×
“Studies with positive findings had unique features such as the exclusion of patients with treatment-resistance depression [39], the use of a treatment period exceeding 4 weeks [39], approximately 75% of the patients with depression with melancholic features [40], about half of subjects with seasonal worsening without…”
BackgroundPharmacological Treatments for Patients with Treatment-Resistant Depression
Ruberto, V. L., Jha, M. K., & Murrough, J. W. (2020) · Pharmaceuticals · doi:10.3390/ph13060116 · Cited by 147
Comparative analysis of observer depression scales
Maier, W., & Philipp, M. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02601.x · Cited by 136 · cited 1×
“Maier–Philipp severity subscale [19], Gibbons global depression severity scale [20], Santen scale [21], anxiety subscale [22], and retardation subscale [23] (Table S1).”
BackgroundAmerican Psychiatric Association (2010) · doi:10.1176/appi.books.9780890423387.654001 · Cited by 134
Light therapy in non-seasonal depression: An update meta-analysis
Tao, L., Jiang, R., Zhang, K., Qian, Z., Chen, P., Lv, Y., & Yao, Y. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113247 · Cited by 129 · cited 9×
“This study’s strength includes being conducted in a subtropical environment (24.5◦–25.5◦ N) on Asians with depression.”
BackgroundMethodResultInfluentialOldham, M. A., & Ciraulo, D. A. (2014) · Chronobiology International · doi:10.3109/07420528.2013.833935 · Cited by 115 · cited 1×
“potential advantage of being effective in modifying circadian phase-shift, sleep, sympathovagal balance, and alertness [5].”
BackgroundHolsboer‐Trachsler, E., Hemmeter, U., Hatzinger, M., Seifritz, E., Gerhard, U., & Hobi, V. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90020-5 · Cited by 113 · cited 1×
“Consistent with prior findings [37,38], BLT was not efficacious as an adjunctive therapy to antidepressants in patients with non-seasonal MDD in the present study.”
ResultAdjunctive Bright Light in Non‐Seasonal Major Depression
Martiny, K. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00460_2.x · Cited by 105 · cited 1×
“Studies with positive findings had unique features such as the exclusion of patients with treatment-resistance depression [39], the use of a treatment period exceeding 4 weeks [39], approximately 75% of the patients with depression with melancholic features [40], about half of subjects with seasonal worsening without…”
BackgroundGeoffroy, P. A., Schroder, C. M., Reynaud, E., & Bourgin, P. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101213 · Cited by 100 · cited 2×
“Given that SSRIs were used in most trials [6,8], various antidepressive agents other than SSRIs are required for further investigation with light therapy.”
BackgroundChronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy
Wirz-Justice, A., Benedetti, F., & Terman, M. (2013) · doi:10.1159/isbn.978-3-318-02091-5 · Cited by 99
Side Effects of Short-Term 10,000-Lux Light Therapy
Kogan, A. O., & Guilford, P. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.293 · Cited by 94 · cited 1×
“The side effects of light therapy were measured using the adverse events scale [32,33] at each visit.”
MethodIntroduction to placebo effects in medicine: mechanisms and clinical implications
Meissner, K., Kohls, N., & Colloca, L. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0414 · Cited by 84 · cited 1×
“There is evidence that the effect of a physical placebo is greater than that of a pharmacological placebo, and that the placebo effect was greater in short-term studies than in long-term ones [47].”
BackgroundSunshine on my shoulders: Weather, pollution, and emotional distress
Beecher, M. E., Eggett, D. L., Erekson, D. M., Rees, L. B., Bingham, J. L., Klundt, J. S., Bailey, R. J., Ripplinger, C., Kirchhoefer, J., Gibson, R., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.021 · Cited by 59 · cited 1×
“Daylength (duration from sunrise to sunset) was used as the parameter of natural daylight [30,31], and the mean daylength was 12h: 9m (SD 1:04, range 10:35–13:42) from June 2019 to May 2020, and there were less seasonal variations than in areas of higher latitudes.”
MethodSanten, G. W. E., Goméni, R., Danhof, M., & Pasqua, O. E. D. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.11.004 · Cited by 58 · cited 1×
“Maier–Philipp severity subscale [19], Gibbons global depression severity scale [20], Santen scale [21], anxiety subscale [22], and retardation subscale [23] (Table S1).”
BackgroundChan, J. W., Lam, S., Li, S. X., Chau, S. W., Chan, S., Chan, N., Zhang, J., & Wing, Y. (2022) · Psychological Medicine · doi:10.1017/s0033291720003232 · Cited by 47 · cited 4×
“Of note, one study [7], conducted in a climate similar to the climate our trial was conducted in, investigated adjunctive light treatment for depressed evening chronotype subjects (n = 93) for 5 weeks, and the between-group effect size was small (Cohen’s d = 0.”
BackgroundResultInfluentialBright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression.
Praško, J. P., Horáček, J., Klaschka, J., Kosová, J., Ondrackova, I., & Sipek, J. (2002) · PubMed · Cited by 45
Seasonality in affective disorders in Switzerland
Wirz‐Justice, A., Graw, P., Kräuchi, K., & Wacker, H. R. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.18.x · Cited by 40 · cited 1×
“The well-being (total scores for mood, social contact, and energy on the Seasonal Pattern Assessment Questionnaire) was lowest in autumn and winter and highest in spring and summer both for SAD and non-SAD cohorts [43].”
BackgroundMartiny, K., Refsgaard, E., Lund, V., Lunde, M., Thougaard, B., Lindberg, L., & Bech, P. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12402 · Cited by 37 · cited 1×
“Eighth, since BLT might need some time to have an effect on depressive symptoms [55], a follow-up assessment for observing long-term effects would be needed.”
BackgroundMeesters, Y., Winthorst, W. H., Duijzer, W. B., & Hommes, V. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0729-5 · Cited by 37
A sham-controlled randomized trial of adjunctive light therapy for non-seasonal depression
Chojnacka, M., Antosik-Wójcińska, A. Z., Dominiak, M., Bzinkowska, D., Borzym, A., Sokół-Szawłowska, M., Bodzak-Opolska, G., Antoniak, D., & Święcicki, Ł. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.062 · Cited by 32
Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression
Fekadu, A., Wooderson, S. C., Rane, L. J., Markopoulou, K., Poon, L., & Cleare, A. J. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105600906 · Cited by 23 · cited 1×
“Generally, patients with depression who do not respond to medications are predicted to exhibit poor symptom outcomes in the future [42].”
BackgroundAntidepressant medication treatment patterns in Asian patients with major depressive disorder
Haro, J. M., Novick, D., Montgomery, W. S., Moneta, V., Peng, X., & Brugnoli, R. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s68432 · Cited by 23 · cited 1×
“Some dosages of the antidepressants administered to our participants were close to the lower limits of the usual dosage, as per the relevant guidelines [9–11], but these conditions were consistent with the common treatment dosages for MDD in Asian patients [12].”
ResultLatitude effect on bipolar temperaments
Kohno, K., Hoaki, N., Inoue, T., Nakai, Y., Toyomaki, A., Araki, Y., Hatano, K., & Terao, T. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.052 · Cited by 20
Inoue, T., Kohno, K., Baba, H., Takeshima, M., Honma, H., Nakai, Y., Suzuki, T., Hatano, K., Arai, H., Matsubara, S., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.049 · Cited by 17
Treuer, T., Liu, C.-Y., Salazar, G., Kongsakon, R., Jia, F., Habil, H., Lee, M., Lowry, A. J., & Dueñas, H. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12090 · Cited by 16
Bipolar temperaments and light
Araki, Y., Terao, T., Hoaki, N., Wang, Y., & Goto, S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.050 · Cited by 15
Beniamino, L., Camardese, G., Serrani, R., Walstra, C., Di Nicola, M., Della Marca, G., Bria, P., & Janiri, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s74861 · Cited by 12
Who is more prone to depression at higher latitudes? Islanders or mainlanders?
de Vliert, E. V., & Rentfrow, P. J. (2021) · Current Research in Ecological and Social Psychology · doi:10.1016/j.cresp.2021.100012 · Cited by 10 · cited 2×
“Daylength (duration from sunrise to sunset) was used as the parameter of natural daylight [30,31], and the mean daylength was 12h: 9m (SD 1:04, range 10:35–13:42) from June 2019 to May 2020, and there were less seasonal variations than in areas of higher latitudes.”
MethodHarada, E., Kato, M., Fujikoshi, S., Wohlreich, M. M., Berggren, L., & Tokuoka, H. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12658 · Cited by 9 · cited 1×
“Maier–Philipp severity subscale [19], Gibbons global depression severity scale [20], Santen scale [21], anxiety subscale [22], and retardation subscale [23] (Table S1).”
Background
Research works printed but not linked: 1
- Terman, M., Rifkin, J.B., Jacobs, J., and White, T.M. (2019, May 01). Morningness-Eveningness Questionnaire-Revised, Self-Assessment Version (MEQ-SA). Trans. Traditional Chinese. New York: Center for Enmvironmental Therapeutics. Available online: https://www.cet.org/wp-content/uploads/2018/01/MEQ-SA-TradChi.pdf.
Cited by
Bright Light Therapy for Nonseasonal Depressive Disorders
Menegaz de Almeida, A., Aquino de Moraes, F. C., Cavalcanti Souza, M. E., Cavalcanti Orestes Cardoso, J. H., Tamashiro, F., Miranda, C., Fernandes, L., Kreuz, M., & Alves Kelly, F. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.2871 · Cited by 47
Illuminating the way: the role of bright light therapy in the treatment of depression
Rajačić, B. K., Šagud, M., Pivac, N., & Begić, D. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2273396 · Cited by 20
Tong, H., Dong, N., Lam, C. L. M., & Lee, T. M. C. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104149 · Cited by 17
Chan, J. W. Y., Feng, H., Zhang, J., Chan, N. Y., Li, T. M. H., Chau, S. W. H., Liu, Y., Li, S. X., & Wing, Y. K. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.10.013 · Cited by 14
Bojarska, W., Bury, K., Januszczak, R., Burda, B., & Pawęzka, J. (2024) · Medical Science Monitor · doi:10.12659/msm.945319 · Cited by 9
Metadata
- Authors
- Chen, I.-P., Huang, C.-C., Huang, H.-C., Yang, F.-P. G., Ko, K.-T., Lee, Y.-T., Sun, F.-J., & Liu, S.-I.
- Affiliations
- Mackay Memorial Hospital (TW)
- National Tsing Hua University (TW)
- National Yang Ming Chiao Tung University (TW)
- Corresponding author
- Liu, Shen-Ing
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2022-09-29
- Volume
- 19
- Issue
- 19
- Pages
- 12430
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC9566126
- OpenAlex
- W4297982458
- Cited by
- 13
- References
- 54
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 3 · 2023: 2
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology, Taiwan (MOST-108-2314-B-195-001, MMH-108-147, MMH-109-98)
- MacKay Memorial Hospital, Taipei, Taiwan (MOST-108-2314-B-195-001, MMH-108-147, MMH-109-98)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- bright light therapy, adjunctive therapy, antidepressant response, subtropical climate, Asian patients, morning light exposure, treatment duration
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Double-Blind Method, Humans, Middle Aged, Phototherapy, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
